P

Program


  • Sessions

  • Day by day

  • Timetable

  • Speakers

  • Speakers

  • Topics

  • Print

Schedule

Wed 7
08:30–13:30 Precongress Course (sold separately)
15:40–21:00
Thu 8 08:30–19:00
Fri 9 08:30–19:00
Sat 10 08:30–14:00

Italian course (ECM)

Pre-congress course

Official Language

English is the official language of the Congress.

CME Accreditation

The scientific programme will be submitted for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME);
The Italian course by AIGE is accredited for 6.30 italian ECM

Opening Lecture

  • (OL01) for the Bruno Lunenfeld Lecture: RANKL – from bone loss to breast cancer

    • Josef M. Penninger (AT) RANKL – from bone loss to breast cancer

Key Lecture

  • (KL01) Endometriosis and adenomyosis in adolescents, fertile and menopausal women

    • Leila Adamyan (RU) Endometriosis and adenomyosis in adolescents, fertile and menopausal women
  • (KL02) Stress, emotional eating, and reproductive function

    • Sarah Berga (US) Stress, emotional eating, and reproductive function
  • (KL03) Menopause hormone therapy after 65: available data, risks and benefits

    • Martin Birkhaeuser (CH) Menopause hormone therapy after 65: available data, risks and benefits
  • (KL04) The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease

    • Roberta Brinton Diaz (US) The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease
  • (KL05) Significance of estrogens metabolites in the pathophysiology of PCOS

    • Luigi Devoto (CL) Significance of estrogens metabolites in the pathophysiology of PCOS
  • (KL06) Molecular pathways of ageing

    • Bruno Lunenfeld (IL) Molecular pathways of ageing
  • (KL07) The ovarian renin-angiotensin system

    • Frederick Naftolin (US) The ovarian renin-angiotensin system
  • (KL08) Hormones and inflammation: an update on endometriosis

    • Felice Petraglia (IT) Hormones and inflammation: an update on endometriosis
  • (KL09) Estetrol treatment of Advanced Breast Cancer

    • Herjan Coelingh Bennink (NL) Estetrol treatment of Advanced Breast Cancer
  • (KL09) The dialogue between the maternal endometrium and the embryo. Potential impact on the onset of adult diseases

    • Carlos Simon (ES) The dialogue between the maternal endometrium and the embryo. Potential impact on the onset of adult diseases
  • (KL10) Pituitary adenomas- clinical challenges

    • Joseph Schenker (IL) Pituitary adenomas- clinical challenges

Symposium

  • (SYMP27) Fertility preservation: possibilities and strategies

    • Cesar Garcia (ES) Oocyte cryopreservation or tissue transplantation for fertility preservation in cancer patients: what is best ?
    • Marie-Madeleine Dolmans (BE) Ovarian tissue cryopreservation and transplantation: which success for 2018 ?
    • Zion Ben Rafael (IL) The dilemma of social freezing
  • (SYMP28) Gynecological symptoms and psycosomatic health

    • Liliana Rocca Gazzuola (US) Adverse childhood or adult experiences and gynecological symptoms
    • Tamaki Matsumoto (JP) Menstrual regularity and irregularity and psychosomatic health of women from the perspective of autonomic nervous system activity
    • Michèle Lachowksy (FR) Endometriosis and infertility, a psychosomatic approach
  • (Symp01) Puberty and adolescence

    • Blazej Meczekalski (PL) Kisspeptin role in functional hypothalamic amenorrhea
    • Camil Castelo Branco (ES) Management of transsexuality in an outpatient gynecologic area
    • George Creatsas (GR) Dysfunctional uterine bleeding in adolescence
    • Vincenzina Bruni (IT) Premature ovarian insufficiency therapy in young women
  • (Symp02) Androgens

    • Charles Sultan (FR) Management of adolescent hyperandrogenism: still a challenge !
    • Angelica Linden Hirschberg (SE) The role of androgens for body composition and physical performance in women
    • Susan Davis (AU) Testosterone and cardiovascular health after menopause, a benefit or risk ?
    • Andrea R. Genazzani (IT) Adrenal androgens: the key difference from other mammals
  • (Symp03) PCO: genetic, epigenetic and metabolic risk factors

    • Jerome F. Strauss (US) Genetic and epigenetic factors contributing to the hyperandrogenemia of PCOS
    • Charles Sultan (FR) Adolescent PCOS: an entity?
    • Alessandro D. Genazzani (IT) Metabolic impairment and new therapeutic strategies for PCOS
    • Andrzej Milewicz (PL) Serum bisphenol A and metabolic profile in women with PCOS
  • (Symp04) Contraception: personalized regimens, new molecules

    • Kristina Gemzell-Danielsson (SE) Contraception for teenagers and young women
    • Johannes Bitzer (CH) Do will still need anti-androgenic progestogens ?
    • Adolf E. Schindler (DE) The role of progestogen-only-pills (POP’s) for contraception and non-contraceptive indications
    • J Michel Foidart (BE) Introducing the first NEST in contraception (native estrogen with selective tissue activity)
  • (Symp05) Contraception: difficult cases

    • Rossella E. Nappi (IT) Hormonally-related headaches
    • Nilson R. De Melo (BR) Contraception in menopausal transition
    • Anna Glasier (GB) The advantages and disadvantages of long-acting reversible contraception (LARC)
    • Peter Chedraui (EC) Contraception in women with cardiovascular risk factors
  • (Symp06) Early pregnancy: a critical period with multiple affecting factors

    • Takeshi Maruo (JP) Thyroid hormone in trophoblast invasion and early pregnancy maintenance
    • Howard Carp (IL) Management of antiphospholipid syndrome in pregnancy
    • Robert Taylor (US) Gap junctions and hormonal regulation of endometrial decidualization
    • Mark Brincat (MT) The IVF/ICSI, early pregnancy interphase
  • (Symp07) Premature labor: how to prevent, how to manage

    • Tomoyuki Fujii (JP) Omega-3 polyunsaturated fatty acid and preterm birth
    • Fabio Facchinetti (IT) Maintenance tocolysis. Still unsolved problem
    • Gian Carlo Di Renzo (IT) Prediction and prevention of preterm birth
    • Christian Egarter (AT) Progesterone: mode of action in preterm labor
  • (Symp08) Progesterone: the life time partner steroid

    • Luigi Devoto (CL) Different pathways of P-receptor complex in the process of ovulation
    • Adolf E. Schindler (DE) Prevention or treatment of pregnancy disorders with progestogens
    • Philipe Bouchard (FR) Progesterone: friend and /or foe on breast and CNS
    • Alfred Mueck (DE) Vascular effects of progestogens
  • (Symp09) Vitamin D

    • Faustino Perez Lopez (ES) Maternal vitamin D and reproductive outcomes
    • Andrzej Milewicz (PL) Serum vitamine D levels and VDR polymorphisms in women with PCOS
    • Mark Brincat (MT) Vitamin D in PCO and endometriosis. Levels and significance
    • Julia Savochkina (BY) Vitamin D level in women with an ovulatory distinction
  • (Symp10) Endometriosis/Adenomyosis: from basic science to clinics

    • Ludwig Kiesel (DE) Regulation of proliferation and invasion in endometriosis
    • Robert Taylor (US) Cell biology of nascent endometriosis implants
    • Steven R. Goldstein (US) The role of transvaginal U/S in the diagnosis of endometriosis and adenomyosis
    • Nicola Pluchino (IT) Role of bone marrow-derived cells in endometriosis development
  • (Symp11) ART – Time is moving: new difficulties and new possibilities

    • Luca Gianaroli (IT) 40 years after Louise Brown
    • Alberto Revelli (IT) Multivariate prediction model for IVF results : a tool to get benchmark
    • Johan Smitz (BE) Can we predict oocyte quality in the ART laboratory ?
    • Pedro N. Barri (ES) Uterine factor in IVF repeated implantation failure
  • (Symp12) ART – New therapies and new challenges: the individual factors

    • Basil Tarlatzis (GR) The use of androgens or androgen – modulating agents in poor responders undergoing in vitro fertilization
    • Paolo Artini (IT) Collapse of blastocysts is correlated to implantation success or not ?
    • Jaques Cohen (US) Assisted reproductive technology treatments, limitations and prospects for mitochondrial disease carriers
    • Anupama Deenadayal –Mettler (DE) Cleavage stage versus blastocyst transfer from the embryologist point of view
  • (Symp13) PCO: ART and pregnancy outcomes

    • Basil Tarlatzis (GR) PCOS: what is the preferred stimulation protocol for IVF ?
    • Xiangyan Ruan (CN) Aromatase inhibitors plus HMG for infertile PCOS women
    • Duru Shah (IN) AMH in PCOS and ART outcome
    • Bart CJM Fauser (NL) Metabolic dysfunction in PCOS: implications for pregnancy and children outcomes
  • (Symp14) Neurosteroids as regenerative agents

    • Roberta Brinton Diaz (US) Allopregnanolone as a therapeutic to regenerate the degenerating brain
    • M. Schumacher (FR) Progesterone and stroke
    • Regine Sitruk – Ware (US) Effects of progesterone and nestorone on myelin
  • (Symp15) Neuroprotection

    • Luis Garcia-Segura (ES) Neuroprotective action of estradiol and estrogen receptors
    • Walter Rocca (US) Sex, gender, and the decline of dementia
    • Andrea R. Genazzani (IT) Adrenal androgens impact on neurosteroids
    • Cordian Beyer (DE) Estradiol control of brain inflammation and pyroptosis
  • (Symp16) Menopausal transition

    • Tommaso Simoncini (IT) Neuroendocrine changes of the menopausal transition
    • Pauline Maki (US) Cognition and hot flashes: a scientific update
    • Mary Ann Lumsden (GB) Following Guidelines – what should we say to those with heart disease ?
    • Santiago Palacios (ES) Effects and management of the menopausal transition on vulvo-vaginal tissue
  • (Symp17) Precision medicine and hormone therapy: right woman, right time, right regimen.

    • Roberta Brinton Diaz (US) The perimenopause is personal: precision hormone therapy to make it precise
    • Pauline Maki (US) A scientific update on the critical window of hormone therapy and cognition: who, what, when ?
    • Regine Sitruk – Ware (US) How to tailor progestin use to individual needs in the post-menopause
    • Andrea R. Genazzani (IT) How long to treat and how adapt the hormone therapy to the overcoming needs
  • (Symp18) Cardiovascular protection and life long risk factors: diagnosis and management

    • Irene Lambrinoudaki (GR) Obstetrical history and cardiovascular risk in later life
    • Sven O. Skouby (DK) HT: pharmacology tailored to women´s health
    • Antonio Cano (ES) Symptoms and hormones: fine-tuning atherosclerotic risk ?
    • Peter Collins (GB) Cardiovascular risk management in women – an update, what’s new ?
  • (Symp19) Cardiovascular protection: the sex steroids challenges

    • Frederick Naftolin (US) Sex steroids block the initiation of atherosclerosis
    • John Stevenson (GB) HRT for primary prevention of CHD
    • Nestor Siseles (AR) Cardiovascular risk in climacteric women: when to begin the hormone treatment ?
    • Tomi Mikkola (FI) Cardiovascular mortality risk and HRT
  • (Symp20) Osteoporosis: a long life risk for women

    • Martin Birkhaeuser (CH) Prevention of osteoporosis in anorexia nervosa: what is new ?
    • Hadji Peyman (DE) Pregnancy associated osteoporosis – what we know and what we don’t
    • John Stevenson (GB) HRT for prevention of osteoporosis
    • Tobias De Villiers (ZA) New drug development in osteoporosis
  • (Symp21) Premature Ovarian Insufficency

    • Farook Al-Azzawi (GB) Determinants of oocytes reserve and depletion
    • Nick Panay (GB) POI: progress through a global registry
    • Bart CJM Fauser (NL) POI: implications for cardiovascular health
    • Svetlana Vujovic (RS) Hypoestrogenism and insulin resistance in premature ovarian insufficiency: is it time dependent ?
  • (Symp22) Depression and cognition in midlife women

    • Luis Garcia-Segura (ES) Estrogenic regulation of neuro-inflammation: implications for depression and cognition
    • Alessandra Graziottin (IT) Osteoarthritis: a neglected trigger of neuroinflammation and depression in women
    • Tory Eisenlohr-Moul (US) Novel methods for clarifying the psychiatric effects of ovarian steroids across the female lifespan
    • John Studd (GB) Estrogens and testosterone for reproductive depression
  • (Symp23) Urogenital aging

    • Nick Panay (GB) Impact and management of VVA / GSM – an evidence based approach
    • Tomi Mikkola (FI) Stress urinary incontinence risk in women using HRT
    • Camil Castelo Branco (ES) VVA in young women
    • Tommaso Simoncini (IT) Managing pelvic organ prolapse between hormones and surgery
  • (Symp24) Breast cancer: clinical impact of latest investigations

    • Nicoletta Biglia (IT) Breast cancer screening today
    • Anne Gompel (FR) When can HT be used in those at increased risk of breast cancer ?
    • Xiangyan Ruan (CN) Membrane-bound-Progesterone-Receptor can predict prognosis of breast cancer
    • Christian Singer (AT) Endocrine therapy and fertility in young breast cancer patients
  • (Symp25) Sexuality all the life

    • Johannes Bitzer (CH) New sexualities – the internet and sex
    • Angelica Linden Hirschberg (SE) Hormonal contraception and impact on sexuality
    • Rossella E. Nappi (IT) Genitourinary syndrome of menopause and impact on women’s life
    • Susan Davis (AU) Sexual wellbeing and older women- what is the data ?
  • (Symp26) Estetrol and Breast Cancer

    Chairperson/s: Nicoletta Biglia (IT), Herjan Coelingh Bennink (NL)

    • Carole Verhoeven (NL) Estrogens and breast cancer treatment
    • Richard J. Santen (US) E4 in animal in vivo studies
    • Risto Erkkola (FI) E4 in human breast cancer cells tissue explants
  • (Symp29) Reproductive impairment: from nature to therapies

    • Alessandro D. Genazzani (IT) Stress and hypothalamic amenorrhea
    • Rossella E. Nappi (IT) New therapies for Impairment of female sexual desire
    • Ashraf Virmani (NL) Male reproductive failure: how to face

Meet the Experts

  • (DEB01) SPRM

    • Philipe Bouchard (FR) Selective progesterone receptor modulators (SPRMs): update on the clinical results in fibroids
    • Kristina Gemzell-Danielsson (SE) SPRMs for contraception with added health benefits
  • (DEB02) Bilateral oophorectomy in pre-menopausal women

    • Walter Rocca (US) It is time to stop unjustified oophorectomies
    • John Studd (GB) It is time we learn to treat oophorectomized women correctly
  • (DEB03) POPULATION COUNCIL-ISGE SESSION: Old needs and new possibilities for women health protection

    • Regine Sitruk – Ware (US) Vaginal rings for dual protection
    • Anna Glasier (GB) Interventions to reduce unintended pregnancy rates
  • (DEB04) The vaginal and endometrial microbiota

    • Gary Ventolini (US) Intravaginal and endometrial microbiota are important for human reproduction
    • Inmaculada Moreno (ES) Study of the endometrial microbiota to improve ART outcomes
  • (DEB05) Stress and reproduction

    • Sarah Berga (US) Does stress causes infertility ?
    • Alessandro D. Genazzani (IT) Integrative treatment to overcome the neuroendocrine impairment
  • (DEB06) Obesity and reproduction: impact in pregnancy and at menopause

    • Moshe Hod (IL) Facing the Non Communicable Disease (NCD) global epidemic – it all starts in utero
    • Peter Chedraui (EC) The metabolic syndrome a pro-inflammatory state before or after the menopause?
  • (DEB08) Ovarian tumors

    • Manuel Noelting (AR) Androgens secreting tumors
    • Pierluigi Benedetti Panici (IT) Update on cytoreductive surger for advanced ovarian cancer

Scientific Society Symposium

  • Alliance of the surgeon and gynecologist-endocrinologist in reproductive medicine – organized by the Russian Association of Endometriosis

    Chairperson/s: Leila Adamyan (RU), Vladimir N. Serov (RU)

  • Alternative treatment methods of patients with benign tumors and hyperplastic processes of the uterus in women of reproductive age- organized by the Russian Society of Reproductive Medicine and Surgery

    Chairperson/s: Leila Adamyan (RU), Vladimir N. Serov (RU)

  • Aspects related to middle-aged women -Organized by the Asociacion Argentina para el estudio del Climaterio (AAPEC) –

    Chairperson/s: Rita Caro (AR), Elida Rodriguez (AR)

    • Claudia Rey (AR) Osteopenia: when and how to intervene ?
    • Monica Nanez (AR) Are local hormones really important in genitourinary urinary tract ?
    • Alejandra Belardo (AR) Sleep disorders in perimenopausal women, and metabolic syndrome
    • Blanca Campostrini (AR) Treatments for menopausal symptoms: which are the best options.?
    • Cristina Montero (AR) Discussion
  • Clinical challenges in the menopause transition – Organized by the Latino-American Federation of Climateric and Menopause Societies (FLASCYM)

    Chairperson/s: Sonia Cerdas (CR), Zully Benitez (PY)

    • Sonia Cerdas (CR) The endocrinology of menopause transition
    • Nestor Siseles (AR) Risks and indications of contraception
    • Alejandro Paradas (DO) Achieving pregnancies during MT
    • Maria Teresa Espinoza (BO) Hot flashes and migraines approach
    • Silvina Witis (AR) Management of abnormal bleeding
    • Celis Cuauhtemoc (MX) Bone health during MT
    • Alejandra Elizalde Cremonte (AR) Questions and closing remarks
    • Greta Solis (NI) Questions and closing remarks
    • Maria Alejandra Schuele (AR) Questions and closing remarks
  • Contraception: interesting aspects – organized by the European Society of Contraception and Reproductive Health (ESC)

    Chairperson/s: Gabriele Merki (CH), George Bartfai (HU)

    • Regine Sitruk – Ware (US) Potential neurological benefits of progesterone and progestins used in contraception
    • Gabriele Merki (CH) Course and treatment of headaches and migraine in the pillfree interval
    • George Bartfai (HU) Contraception in women with seizure disorder
  • Endocrine disorders during pregnancy- Organized by the Hungarian Society of Gynecological Endocrinology (HSGE)-

    Chairperson/s: Andras Szilagyi (HU), Gyorgy Bartfai (HU)

    • Attila Jakab (HU) Adverse perinatal outcome of pregnancies after ART: twins are responsible for everything ?
    • Szabolcs Varbiro (HU) Effect of vitamin D deficiency and supplementation in PCOS patients on fertility and pregnancy
    • Tamas Deli (HU) Effect of endocrine disorders on fertility and fetal and maternal obstetrical outcomes
    • Imre Kun Tormasi (HU) Association of pathological tyrosine isoforms with parameters of hematopoiesis in
      hyperfiltrating physiological pregnant women
    • Monika Orosz (HU) Hyperprolactinaemia in young women: treatment and follow-up of the infertile patient
    • Petra Merkely (HU) Gender difference in sport related vascular adaptation of gracilis arterioles in a rat model
    • Szilvia Csehely (HU) Laboratory and etiology characteristics of PCOS phenotypes
  • Gynecological Endocrinology and the Women Health’s future – Organized by the Asociacion Latinoamericana de Endocrinología Ginecologica (ALEG)

    Chairperson/s: Alejandro Paradas Caba (DO), Alejandro Manzur (CL)

    • German Salazar (CO) Trends in contraceptives use among adolescents
    • Imelda Hernandez (MX) Long term polycystic ovarian syndrome complications
    • Selva Lima (UY) Obesity its gynecological endocrine repercussion
    • Celis Cuauhtemoc (MX) MHT: risks and benefits
    • Gerardo Broutin (CR) conclusions
    • Lidia Sosa (PY) conclusions
  • Hot topics in Gynecological Endocrinology -Organized by the Polish Society of Gynecological Endocrinology-

    Chairperson/s: Blazej Meczekalski (PL), Andrzej Milewicz (PL)

    • Grzegorz Breborowicz (PL) Obesity – what kind of problem it is in contemporary perinatology ?
    • Agnieszka Podfigurna (PL) Hyperandrogenism related to androgen secreting ovarian tumors
    • Krzysztof Lukaszuk (PL) Endometrial receptivity and luteal phase support
    • Blazej Meczekalski (PL) Fertility in women of late reproductive age
  • Male Contraception under the auspices of ICMC – Organized by the International Consortium for Male Contraception (ICMC)

    Chairperson/s: David Serfaty (FR), Regine Sitruk-Ware (US)

    • David Serfaty (FR) Activities and update of ICMC
    • Cristina Meriggiola (IT) Overview on male hormonal contraception
    • Regine Sitruk – Ware (US) Possible non contraceptive benefits of hormonal male contraception
    • Mario Festin (CH) WHO efficacy study on male contaception: last update
  • Management of healthy ageing Organized by the European Menopause and Andropause Society (EMAS)

    Chairperson/s: Tommaso Simoncini (IT), Irene Lambrinoudaki (GR)

    • Antonio Cano (ES) Concept of healthy ageing according to EIP on AHA
    • Margaret Rees (GB) Diet and lifestyle interventions for midlife health and beyond
    • Alfred Mueck (DE) Impact of menopausal hormone therapy on morbidity and mortality
    • Mick van Trotsenburg (NL) Ageing in transgender men and women
  • Menopause medicine: think sexuality ! – Organized by the International Menopause Society (IMS)

    Chairperson/s: Mary Ann Lumsden (GB)

    • johannes bitzer (CH) Sexuality and the postmenopausal woman
    • Rossella E. Nappi (IT) Treating sexual symptoms at midlife
    • Susan Davis (AU) Treating sexual symptoms at midlife
  • New research in Chinese women – Organized by the Chinese Society of Gynecological Endocrinology affilated to ISGE-

    Chairperson/s: Xiangyan Ruan (CN), Alfred Mueck (DE)

    • Xiangyan Ruan (CN) Ovarian tissue retransplantation in cancer patients – first center in China
    • Wei Huang (CN) PCOS with metabolic disorders: Treatment wird insulin sensitizer and lifestyle change
    • Jinfang Lin (CN) Management of PCOS patients with endometrial hyperplasia and early adenocarcinoma
  • Panel Discussion “From Conception to delivery in Indian PCOS” – Organized by the PCOS Society of India

    Chairperson/s: Sujata Kar (IN)

    • Nalini Mahajan (IN) .
    • Anita Soni (IN) .
    • Ritu Joshi (IN) .
    • Madhuri Patil (IN) .
  • Role of progestogens in women’s health: an up-date – Organized by the European Progestogen Club (EPC)-

    Chairperson/s: Adolf E. Schindler (DE), René Druckmann (FR)

    • Pedro Antonio Regidor (DE) Clinical relevance in present day hormonal contraception
    • Alfred Mueck (DE) Choice of progestogen for HRT in menopausal women
    • Sven O. Skouby (DK) Impact of progestogenes on hemostasis
    • Vitaliy Tskhay (RU) Operation and hormonal treatment of adenomyosis
  • Session of the SOBRAGE – organized by the Sociedade Brasileira de Ginecologia Endocrina (SOBRAGE)

    Chairperson/s: Sebastiao de Medeiros (BR)

    • Hugo Maia Jr. (BR) Treatment of deep endometriosis pain with vaginal gestrinone and Nf-Kappa.b inhibitors in pentravan
    • Rogerio Bonassi (BR) The role of Vitamin D3 in the management of myomas
    • Sebastiao de Medeiros (BR) New insights in the treatment of ovarian polycistic disease
  • Surgery tbd – Organized by the International Academy of Human Reproduction (IAHR)

    • Liselotte Mettler (DE) Fibroids and malignancy potentials in reproductive surgery
    • Joseph Schenker (IL) Complications of ART technology
    • Andrea Giannini Tommaso Simoncini, (IT) Horizons in gynecologic robotic surgery
  • Unmet needs in sexual care- organized by the Federazione Italiana di Sessuologia Scientifica (FISS)

    Chairperson/s: Vieri Boncinelli (IT), Salvatore Caruso (IT)

    • Chiara Simonelli (IT) Female genital-pelvic pain disorders
    • Elena Lenzi (IT) Female sexual dysfunctions and couple-based clinical interventions
    • Salvatore Caruso (IT) No drug treatment for women with sexual dysfunction
  • Update in Ovarian Cancer- Organized by the Société Européenne de Langue Franco-Allemande de Gynécologie-Obstétrique (SELFAGO)

    Chairperson/s: Adolf E. Schindler (DE), René Druckmann (FR)

    • Laura Knabben (CH) Genetic testing in ovarian cancer
    • Christian Singer (AT) Prevention strategies in women with hereditary breast and ovarian cancer syndromes
    • Walther Kuhn (DE) Impact of lymph node dissection in ovarien cancer
    • Emmanuel Barranger (FR) Advanced ovarien cancer: preoperative prediction of resectibility
  • Women in her psychoneuroimmunoendocrinologycal universe – Organized by the Sociedad Argentina de Endocrinologia Ginecologica y Reproductiva(SAEGRE)

    Chairperson/s: Manuel Nolting (AR)

    • Sandra Demayo (AR) PCOS, Insulin- resistant and mood disorder: an intricately overlapped story
    • Amalia Adriana Monastero (AR) Stress and the onset of oncological pathologies: the worst oulet
    • Susana Pilnik (AR) Transition to menopause: emotional vulnerability to falling hormones
  • tbd – Organized by the European Society of Gynecology (ESG)

  • tbd- Organized by the Federacion Latina de Endocrinología Ginecologica (FLEG)

Corso Superiore di Ginecologia Endocrinologica AIGE

  • (CORSO AIGE01) PCOS e dismetabolismo

    Chairperson/s: Alessandro Genazzani (IT)

    • Vincenzina Bruni (IT) Fattori genetici ed epigenetici predisponenti la PCOS
    • Antonio Cianci (IT) L’ insulino resistenza della PCOS e le strategie terapeutiche
    • Antonio Lanzone (IT) Il trattamento degli iperandrogenismi
    • Chiara Benedetto (IT) PCOS e rischio oncologico
  • (CORSO AIGE02) Management della Terapia Ormonale Sostitutiva

    Chairperson/s: Carmine Nappi (IT)

    • Rossella E. Nappi (IT) Sintomi climaterici come marker di vulnerabilità biologica
    • Anna Maria Paoletti (IT) Quando integrazione e quando sostituzione ormonale
    • Vincenzo De Leo (IT) PCOS e menopausa: nuove opzioni terapeutiche
    • Angelo Cagnacci (IT) L’evoluzione della TOS: combinata ciclica o continua, steroidi di sintesi o TSEC
  • (CORSO AIGE03) Endometriosi e dolore pelvico cronico

    Chairperson/s: Luigi Venturini (IT)

    • Stefano Luisi (IT) Le basi fisiopatologiche dell’endometriosi e le scelte terapeutiche
    • Stefano Angioni (IT) Chirurgia dell’endometriosi: quando e quanto radicale ?
    • Antonio La Marca (IT) La paziente con endometriosi alla ricerca di una gravidanza: come procedere ?
    • Alessandra Graziottin (IT) Dolore pelvico cronico non da endometriosi : diagnosi e strategie terapeutiche

Pre-Congress Course

  • (Pre-Congress Course) Menstrual cycle disorders: from adolescence to menopause

    • Frederick Naftolin (US) The hypothalamic-pituitary-gonadal axis: puberty, menstrual cycle regulation and post-reproductive life
    • Sarah Berga (US) Hypothalamic amenorrhea
    • Basil Tarlatzis (GR) Polycystic ovary syndrome
    • Alessandro D. Genazzani (IT) Metabolism, obesity, thinness and reproduction
    • Steven R. Goldstein (US) Abnormal uterine bleeding: the standard of care has changed
    • Nick Panay (GB) Practical approaches to managing premature ovarian insufficiency

ISGE General Assembly

  • ISGE Genral Assembly